Adults of all ages mount robust T-cell responses to COVID-19 vaccination, which are further boosted by breakthrough infection

A CITF-funded study, published in preprint and not yet peer-reviewed, found that adults, including older adults (65-93 years), mount robust T-cell responses to two- and three-dose COVID-19 mRNA vaccination.